GENERAL ORTHOPAEDICS
Routine thromboprophylaxis appears unnecessary following knee arthroscopy and lower-leg casting
N Engl J Med. 2017 Feb 9;376(6):515-525.1543 patients undergoing knee arthroscopy (POT-KAST trial) and 1519 patients undergoing casting of the lower leg (POT-CAST trial) were randomized to receive or not anticoagulant therapy. The aim of these studies was to examine the efficacy of thromboprophylaxis in these groups of patients. The result of these trials indicated that the use of low-molecular-weight heparin did not reduce the rate of symptomatic venous thromboembolism in either patient population compared to no anticoagulant treatment.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
